BlackRock’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-167,949
| Closed | -$113K | – | 5512 |
|
|
2023
Q2 | $113K | Sell |
167,949
-90
| -0.1% | -$60 | ﹤0.01% | 4788 |
|
|
2023
Q1 | $234K | Sell |
168,039
-145
| -0.1% | -$202 | ﹤0.01% | 4649 |
|
|
2022
Q4 | $212K | Sell |
168,184
-187
| -0.1% | -$236 | ﹤0.01% | 4753 |
|
|
2022
Q3 | $724K | Sell |
168,371
-169
| -0.1% | -$727 | ﹤0.01% | 4511 |
|
|
2022
Q2 | $880K | Sell |
168,540
-530,980
| -76% | -$2.77M | ﹤0.01% | 4499 |
|
|
2022
Q1 | $8.39M | Sell |
699,520
-8,720
| -1% | -$105K | ﹤0.01% | 3591 |
|
|
2021
Q4 | $13.9M | Buy |
708,240
+29,927
| +4% | +$586K | ﹤0.01% | 3419 |
|
|
2021
Q3 | $17.6M | Buy |
678,313
+4,086
| +0.6% | +$106K | ﹤0.01% | 3317 |
|
|
2021
Q2 | $14.8M | Buy |
674,227
+486,175
| +259% | +$10.7M | ﹤0.01% | 3414 |
|
|
2021
Q1 | $4.4M | Buy |
188,052
+36,300
| +24% | +$849K | ﹤0.01% | 3935 |
|
|
2020
Q4 | $2.61M | Buy |
151,752
+138,153
| +1,016% | +$2.37M | ﹤0.01% | 3881 |
|
|
2020
Q3 | $221K | Hold |
13,599
| – | – | ﹤0.01% | 4289 |
|
|
2020
Q2 | $156K | Sell |
13,599
-4,160
| -23% | -$47.7K | ﹤0.01% | 4326 |
|
|
2020
Q1 | $178K | Sell |
17,759
-147
| -0.8% | -$1.47K | ﹤0.01% | 4178 |
|
|
2019
Q4 | $200K | Buy |
17,906
+816
| +5% | +$9.11K | ﹤0.01% | 4256 |
|
|
2019
Q3 | $365K | Sell |
17,090
-250
| -1% | -$5.34K | ﹤0.01% | 4169 |
|
|
2019
Q2 | $402K | Sell |
17,340
-43,134
| -71% | -$1,000K | ﹤0.01% | 4178 |
|
|
2019
Q1 | $2.33M | Sell |
60,474
-2,516
| -4% | -$97.1K | ﹤0.01% | 3612 |
|
|
2018
Q4 | $2.91M | Buy |
62,990
+3,802
| +6% | +$176K | ﹤0.01% | 3536 |
|
|
2018
Q3 | $8.08M | Buy |
59,188
+15,057
| +34% | +$2.06M | ﹤0.01% | 3304 |
|
|
2018
Q2 | $20.8M | Buy |
44,131
+44,070
| +72,246% | +$20.8M | ﹤0.01% | 2811 |
|
|
2018
Q1 | $34K | Buy |
+61
| New | +$34K | ﹤0.01% | 4448 |
|